Johnson & Johnson

JLABS | Paths to the patient: Business models for drug discovery and development   Turning a drug discovery into patient impact means choosing the right development path and knowing when to pivot. But how do you choose the best route for your drug?   Join Johnson & Johnson’s upcoming program as they bring together experts […]